Interestingly, CD8 TILs from patients with DNA mismatch repair-deficient or microsatellite instability-high (MSIhigh) colon cancer had a high frequency of DP CD8 T cells and this group has been associated with increased responsiveness to immunotherapy25–28. The gene discussed is CD8A; the disease is malignant colon neoplasm.